Cold-air anesthesia reduces pain of laser treatment

June 22, 2012 in Diseases, Conditions, Syndromes

Cold-Air anesthesia reduces pain of laser treatment

In ablative fractionated carbon-dioxide laser treatment for photoaging, cold-air anesthesia used in conjunction with topical anesthesia reduces pain significantly more than topical anesthesia alone, according to research published online June 13 in the Journal of the American Academy of Dermatology.

(HealthDay) -- In ablative fractionated carbon-dioxide (CO2) laser treatment for photoaging, cold-air anesthesia used in conjunction with topical anesthesia reduces pain significantly more than topical anesthesia alone, according to research published online June 13 in the Journal of the American Academy of Dermatology.

Emily P. Tierney, M.D., of the Tufts University School of Medicine in Boston, and C. William Hanke, M.D., M.P.H., of St. Vincent Hospital in Carmel, Ind., conducted a prospective split-face study involving 15 patients undergoing ablative fractionated CO2 for photoaging. Patients and physicians rated the perceived discomfort of the treatment on each side of the face to assess whether forced cold-air anesthesia could reduce the discomfort of the laser procedure.

The researchers found that the mean patient-reported was statistically significantly lower with cold-air anesthesia and topical anesthesia, at 4.27 (on a scale from 0 to 10) compared with 7.47 for topical anesthesia alone. The mean physician-reported scores were similar, at 3.73 for cold-air anesthesia and topical anesthesia compared with 7.8 for topical anesthesia alone (P < 0.01).

"The use of forced cold air in conjunction with ablative fractionated CO2 laser is a practical, well-tolerated modality that allows performance of the procedure with minimal discomfort in the absence of sedation, anesthesia, and narcotic analgesia," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Journal reference: Journal of the American Academy of Dermatology search and more info website

Copyright © 2012 HealthDay. All rights reserved.

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

FDA warns of infections tied to Tennessee pharmacy

(AP)—Government health officials are investigating several health problems reported with potentially contaminated medications made by a Tennessee specialty pharmacy.

Diseases, Conditions, Syndromes created 20 hours ago | popularity not rated yet | comments 0

Comorbidities common with alopecia areata

(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.

Diseases, Conditions, Syndromes created 21 hours ago | popularity not rated yet | comments 0

Top-ranked golfer beats scoliosis

(HealthDay)—As a world-class golfer, Stacy Lewis' accomplishments are remarkable. But it was a physical challenge in her childhood that defined her ascent to the top of her sport.

Diseases, Conditions, Syndromes created 22 hours ago | popularity not rated yet | comments 0

Saudi to send animal samples to US in coronavirus probe (Update)

Saudi Arabia said Friday it would send samples taken from animals possibly infected with a deadly SARS-like virus to the United States for testing in a bid to find the source of disease.

Diseases, Conditions, Syndromes created May 24, 2013 | popularity not rated yet | comments 0

WHO voices deep concern over spread of SARS-like virus

The World Health Organization voiced deep concern Thursday over the SARS-like virus that has killed 22 people in less than a year, saying it might potentially spread more widely between humans.

Diseases, Conditions, Syndromes created May 24, 2013 | popularity 5 / 5 (1) | comments 0


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Hormone levels may provide key to understanding psychological disorders in women

Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Going live: Immune cell activation in multiple sclerosis

Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...